Wnt
The Wnt signaling pathways are a group of signal transduction pathways made of proteins that pass signals from outside of a cell through cell surface receptors to the inside of the cell. Three Wnt signaling pathways have been characterized: the canonical Wnt pathway, the noncanonical planar cell polarity pathway, and the noncanonical Wnt/calcium pathway. All three Wnt signaling pathways are activated by the binding of a Wnt-protein ligand to a Frizzled family receptor, which passes the biological signal to the protein Dishevelled inside the cell. The canonical Wnt pathway leads to regulation of gene transcription, the noncanonical planar cell polarity pathway regulates the cytoskeleton that is responsible for the shape of the cell, and the noncanonical Wnt/calcium pathway regulates calcium inside the cell. The clinical importance of Wnt signaling pathway has been demonstrated by mutations that lead to a variety of diseases, including breast and prostate cancer, glioblastoma, type II diabetes.
Wnt Isoform Specific Products
All Product Categories
-
Wnt Related Products (441)
Related Products (441)
-
Antibodies (26)
-
Wnt Isoform Comparison
By Targets:
Loading...
Show More (155)
By Isoforms:
Loading...
By Effects:
Loading...
By Disease Areas:
Loading...
Show More (10)
Wnt Related Products
Related Products
Clear Filters
-
Murrayafoline A (Standard)
0 ImagesCat. No.: HY-W100287RCAS No.: 4532-33-6Murrayafoline A (Standard) is the analytical standard of Murrayafoline A (HY-W100287). This product is intended for research and analytical applications. Murrayafoline A is a carbazole alkaloid that can be extracted from Murraya tetramera. Murrayafoline A directly targets Specificity protein 1 (Sp1), thereby inhibiting NF-κB and MAPK signaling pathways. Murrayafoline a induces a G0/G1-phase arrest in platelet-derived growth factor (PDGF)-stimulated vascular smooth muscle cells. Murrayafoline A attenuates the Wnt/β-catenin pathway by promoting the degradation of intracellular β-catenin proteins. Murrayafoline A enhances the contraction of rat ventricular myocytes and L-type calcium current by activating protein kinase C. Murrayafoline A inhibits LPS (HY-D1056)-induced neuroinflammation in vivo. Murrayafoline A can be used for the study of inflammation, vascular complications and colon cancer. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
By Hosts:
Loading...
No matching results
Show More (6)
Show Less
By Reactivities:
Loading...
No matching results
Show More (6)
Show Less
By Applications:
Loading...
No matching results
Show More (6)
Show Less
By Isotypes:
Loading...
No matching results
Show More (6)
Show Less
By Conjugations:
Loading...
No matching results
Show More (6)
Show Less
By Target Specificities:
Loading...
No matching results
Show More (6)
Show Less
By Antibody Forms
Loading...
No matching results
Show More (6)
Show Less
By Minimal Cross Reactivities:
Loading...
No matching results
Show More (6)
Show Less
By Clonalities:
Loading...
No matching results
Show More (6)
Show Less
By Modifications:
Loading...
No matching results
Show More (6)
Show Less
Antibodies
Clear Filters
Your Search Returned No Results.
Sorry. There is currently no product that acts on isoform Bcl-2, Bcl-W and Bim together.Please
try each isoform separately.